This stromal ablation of CXCR2 inhibited tumor growth, reduced immunosuppression by lowering infiltration of MDSCs, and reduced angiogenesis, but also increased the fibrotic reaction in the primary tumor and increased metastasis. Here, CXCR2 is linked to neoplasm.